From: Trabectedin therapy as an emerging treatment strategy for recurrent platinum-sensitive ovarian cancer
Term
Time from last platinum treatment to relapse
Platinum-refractory
During platinum treatment or within 4 weeks of last administration
Platinum-resistant
< 6 months
Partially platinum-sensitive
6 to 12 months
Platinum-sensitive
More than 12 months